Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

Mise à jour : Il y a 4 ans
Référence : NCT02304081

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to evaluate alpha- and beta-cell function during combination treatment with saxagliptin in addition to dapagliflozin and metformin compared to placebo in addition to dapagliflozin and metformin in subjects with T2DM on stable metformin background therapy.


Critère d'inclusion

  • Type2 diabetes mellitus

Liens